News Feature | Published:

Made in Africa

Nature Medicine volume 19, pages 803806 (2013) | Download Citation


This article has been updated

The resource-poor countries of Africa have traditionally relied on Western nations for their drug supply, but a new drug development center with a promising antimalarial agent could pave the way for a homegrown pharmaceutical pipeline. Linda Nordling investigates how this one facility at the southern tip of the continent promises to embolden an entire African drug industry.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 29 July 2013

     Two photo credits in the July 2013 news feature, entitled “Made in Africa” (Nat. Med. 19, 803–806, 2013), were mistakenly reversed. The picture on page 804 was taken by Katherine Traut, and the picture on page 806 was taken by Peter Rimmel. The error has been corrected in the HTML and PDF versions of the article.


  1. 1.

    et al. J. Med. Chem. 55, 3479–3487 (2012)

  2. 2.

    et al. J. Med. Chem. 50, 6307–6315 (2007).

  3. 3.

    et al. Nature 465, 305–310 (2010).

  4. 4.

    et al. J. Med. Chem. 55, 11022–11030 (2012).

Download references

Author information


  1. Linda Nordling is a science journalist based in Cape Town, South Africa.

    • Linda Nordling


  1. Search for Linda Nordling in:

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing